Home › Funds › Kooman & Associates › JNJ

Kooman & Associates position in JNJ

JOHNSON & JOHNSON · Health Care

Kooman & Associates reported holding 1,051 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$278K, representing 0.07% of its reported portfolio and ranking #48 among its reported holdings. Kooman & Associates has disclosed JNJ holdings in 8 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)1.05K sh
Reported value held$278.24K
Portfolio Weight0.07%
First reportedQ3 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Kooman & Associates's JNJ position evolved

Kooman & Associates first disclosed a stake in JNJ in Q3 2024 at 1,549 shares (US$251K). The position peaked in Q3 2025 at 1,783 shares, worth US$331K. Across 8 filings, Kooman & Associates increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,051 shares valued at US$278K — an increase of 53 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.55K $251.03K New
Q1 2025 1.91K $316.92K New
Q2 2025 1.88K $287.17K Reduce
Q3 2025 1.78K $330.60K Reduce
Q4 2025 1.45K $300.08K Reduce
Q1 2026 1.03K $251.77K Reduce
Q2 2026 998 $253.46K Reduce
Q3 2026 1.05K $278.24K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Kooman & Associates held JNJ?

Kooman & Associates has disclosed JNJ holdings in 8 of the last 9 reported quarters, going back to Q3 2024.

What is Kooman & Associates's current position in JNJ?

As of Q3 2026, Kooman & Associates holds 1.05K shares of JNJ (JOHNSON & JOHNSON), valued at $278.24K, representing 0.07% of its reported portfolio and ranking #48.

Has Kooman & Associates been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Kooman & Associates increased its position in JNJ. The position peaked in Q3 2025 at 1.78K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.